Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$979K Sell
623,876
-250,636
-29% -$452K ﹤0.01% 2588
2025
Q4
$1.62M Buy
874,512
+2
+0% +$3 ﹤0.01% 2380
2025
Q3
$1.4M Buy
874,510
+387,249
+79% +$708K ﹤0.01% 2458
2025
Q2
$848K Buy
487,261
+259,460
+114% +$434K ﹤0.01% 2682
2025
Q1
$547K Hold
227,801
﹤0.01% 2879
2024
Q4
$806K Buy
227,801
+6
+0% +$24 ﹤0.01% 2797
2024
Q3
$964K Sell
227,795
-13
-0% -$56 ﹤0.01% 2784
2024
Q2
$854K Buy
227,808
+2
+0% +$9 ﹤0.01% 2793
2024
Q1
$1.23M Sell
227,806
-54
-0% -$311 ﹤0.01% 2616
2023
Q4
$1.41M Buy
227,860
+1,807
+0.8% +$8.89K ﹤0.01% 2581
2023
Q3
$1.17M Sell
226,053
-59,042
-21% -$315K ﹤0.01% 2515
2023
Q2
$1.43M Buy
285,095
+23,235
+9% +$94.2K ﹤0.01% 2496
2023
Q1
$964K Buy
261,860
+37,446
+17% +$141K ﹤0.01% 2625
2022
Q4
$808K Buy
+224,414
New +$1.18M ﹤0.01% 2760

Other funds holding OABI

Nuveen's OABI Position: Q1 2026 in Review

Nuveen reduced its OmniAb (OABI) stake by 29% in Q1 2026, selling an estimated $452K and leaving 623,876 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #2588.

Nuveen first reported a position in OABI in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.62M in Q4 2025. 128 funds tracked by Wall St. Rank hold OABI as of Q1 2026.

  • Nuveen held 623,876 shares of OmniAb worth $979K as of Q1 2026.
  • Nuveen sold 250,636 OmniAb shares in Q1 2026, an estimated $452K.
  • OmniAb made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2588 holding.
  • Nuveen first reported a position in OmniAb in Q4 2022 and has held it in 14 quarters since.
  • Nuveen's OmniAb position peaked at $1.62M in Q4 2025.
  • 128 funds tracked by Wall St. Rank held OmniAb as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.